This trial is examining two different study periods in order to gather information on the referral process for treatment and to learn about the relationships between medical and communitybehavioral health providers.
- Opioid Addiction
4 Primary · 2 Secondary · Reporting Duration: 6 months and 12 months post-release
2 Treatment Groups
Vertical implementation approach
1 of 2
Horizontal implementation approach
1 of 2
18 Total Participants · 2 Treatment Groups
Primary Treatment: TCU Opioid-Treatment Linkage Model (O-TLM) · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many people will be given the opportunity to participate in this clinical trial?
"Yes, the trial is currently ongoing and recruiting patients. It was first posted on October 7th 2021 and was last updated February 28th 2022. The study needs 18 more participants at 1 site." - Anonymous Online Contributor
Are we still looking for people to participate in this research project?
"From what is published on clinicaltrials.gov, this clinical trial is still looking for test subjects. The original posting date was 10/7/2021 with the latest update on 2/28/2022." - Anonymous Online Contributor
What are the dangers associated with TCU Opioid-Treatment Linkage Model (O-TLM)?
"While there is some data supporting the safety of TCU Opioid-Treatment Linkage Model (O-TLM), it falls into Phase 2 of clinical trials and has not yet been proven effective. Consequently, our team at Power rates its safety a 2." - Anonymous Online Contributor